Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-24

Clinical Trial Update: Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating insulin in combination with abatacept in recently diagnosed Type 1 diabetes has completed. The snippet does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abatacept (abatacept)
  • Insulin (insulin)

Snippet

Sponsor: Melbourne Health | Conditions: Type 1 Diabetes, Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED